Analystreport

Autolus Therapeutics plc (NASDAQ: AUTL) is now covered by analysts at Bryan, Garnier & Co. They set a "buy" rating and a $5.00 price target on the stock.

Autolus Therapeutics plc - American Depositary Shares  (AUTL) 
Last autolus therapeutics plc - american depositary shares earnings: 11/7 07:06 am Check Earnings Report
US:NASDAQ Investor Relations: autolus.com/investor-relations